dacarbazine
PolandDrugs containing this active substance
-
The medicinal product is used in the treatment of cancers, such as advanced malignant melanoma (skin cancer), Hodgkin's disease (lymphatic system cancer), and soft tissue sarcomas. It may be administered in combination with other anticancer drugs.
Form: powder for preparation of solution for injection or infusion
Active substance Dosage dacarbazine 100 mg ATC: L01AX04
Manufacturer: medac GmbH for Clinical Special Preparations
-
The medicine is used in the treatment of advanced malignant melanoma (skin cancer), Hodgkin's disease (lymphatic system cancer), and soft tissue sarcoma.
Form: solution for infusion, powder for preparation of
Active substance Dosage dacarbazine 1000 mg ATC: L01AX04
Manufacturer: medac GmbH for Clinical Special Preparations
-
The medicine is used to treat cancers such as advanced malignant melanoma (skin cancer), Hodgkin's disease (lymphatic system cancer), and soft tissue sarcomas. It may be administered in combination with other anticancer medicines.
Form: powder for preparation of solution for injection or infusion
Active substance Dosage dacarbazine 200 mg ATC: L01AX04
Manufacturer: medac GmbH for Clinical Special Preparations
-
The medicine is used to treat cancers such as advanced malignant melanoma (skin cancer), Hodgkin's disease (lymphatic system cancer), and soft tissue sarcomas.
Form: solution for infusion, powder for preparation of
Active substance Dosage dacarbazine 500 mg ATC: L01AX04
Manufacturer: medac GmbH for Clinical Special Preparations